药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chloroprocaine
Afelimomab
The metabolism of Temsirolimus can be increased when combined with Afelimomab.
Chloroprocaine
Abatacept
The metabolism of Temsirolimus can be increased when combined with Abatacept.
Chloroprocaine
Cyclopenthiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Temsirolimus.
Chloroprocaine
Mebutizide
The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Temsirolimus.
Chloroprocaine
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Temsirolimus.
Chloroprocaine
Troxerutin
The risk or severity of bleeding can be increased when Troxerutin is combined with Temsirolimus.
Chloroprocaine
Dabigatran
The risk or severity of bleeding can be increased when Dabigatran is combined with Temsirolimus.
Chloroprocaine
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Temsirolimus.
Chloroprocaine
Tocopherylquinone
The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Temsirolimus.
Chloroprocaine
Melagatran
The risk or severity of bleeding can be increased when Melagatran is combined with Temsirolimus.
Chloroprocaine
Brinase
The risk or severity of bleeding can be increased when Brinase is combined with Temsirolimus.
Chloroprocaine
Protein S human
The risk or severity of bleeding can be increased when Protein S human is combined with Temsirolimus.
Chloroprocaine
Gabexate
The risk or severity of bleeding can be increased when Gabexate is combined with Temsirolimus.
Chloroprocaine
Monteplase
The risk or severity of bleeding can be increased when Monteplase is combined with Temsirolimus.
Chloroprocaine
Nafamostat
The risk or severity of bleeding can be increased when Nafamostat is combined with Temsirolimus.
Chloroprocaine
Darexaban
The risk or severity of bleeding can be increased when Darexaban is combined with Temsirolimus.
Chloroprocaine
Letaxaban
The risk or severity of bleeding can be increased when Letaxaban is combined with Temsirolimus.
Chloroprocaine
Antithrombin III human
The risk or severity of bleeding can be increased when Antithrombin III human is combined with Temsirolimus.
Chloroprocaine
Protein C
The risk or severity of bleeding can be increased when Protein C is combined with Temsirolimus.
Chloroprocaine
Antithrombin Alfa
The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Temsirolimus.